SEMIC EyeScan®


Safe, non-invasive and sustainably environmentally friendly - novel COVID-19 test method delivers results in 3 minutes or less, executable with any smartphone

We are expecting FDA approval soon.

SEMIC EyeScan® is a world first! The internationally patented, purely non-invasive test method, powered by (SEMIC EMILI®), is able to determine within only 3 minutes whether a COVID-19 infection is present. This method achieves a hit rate (sensitivity/specificity) of 97.5% by taking an image of the right or left eye (the evaluation on the left eye is faster)..

SEMIC EyeScan® also determines whether an examined person may have been previously infected with the SARS-CoV-2 virus and captures all known and future mutations.

The digital results can be stored on a terminal device (smartphone, tablet or PC) and, if desired, automatically forwarded to all stakeholders, such as the tested persons themselves, health authorities, CDC, mobile units, local testing centers, foster homes, hospitals, etc. in real time. The geo-tracing and geo-fencing capabilities of SEMIC EyeScan® provide the ability to detect infection clusters and interrupt infection chains anywhere.

SEMIC EyeScan® enables the infection result to be automatically stored as a tamper-proof QR code on the test person's user device.

By using multiple cameras, scans of up to 4 million are possible in one go, with all results displayed within a maximum of 3 minutes. The built-in language option allows the test results to be displayed in any desired world language.

The results of the SEMIC EyeScan® are available more quickly than with all previously known test methods. In addition, the digital diagnostic procedure is sustainably environmentally friendly. There is no need for time-consuming training. The test can be performed independently from home. No protective clothing required when the test is performed via remote video link.

Available Versions:

SEMIC EyeScan® Express: displays positive/negative infection.

SEMIC EyeScan® QRC: displays positive/negative infection and stores secured QR code results.

SEMIC EyeScan® Enhancer: displays positive/negative infection, stores QR codes and displays actual WHO mutation name.

SEMIC EyeScan® Premium: displays positive/negative infection, stores QR codes, displays WHO mutation name and evaluates a newly detected mutation variant for infectious risk class and severity of an infection course within 24 hours.

SEMIC EyeScan® Professional: displays positive/negative infection, stores QR codes, displays the WHO mutation name, evaluates a newly detected mutation variant for infectious risk class and severity of an infection course within 24 hours. Includes automated detection of infection foci with interruption of existing infection chains.

Due to the US HIPAA and EU-GDPR data protection guidelines, SEMIC EyeScan® operates the proprietary technology of Sterile Computing, which fully meets these conditions. Personal data won’t be transferred to any third parties and remains on the user device after automatic deletion of the executing programs at the end of the evaluation only.

Technically required equipment:

User device such as smartphone (at least 6th generation iOS), iPad (at least 2nd generation) or Android (at least V.10), tablet or PC with built-in 12 megapixel camera or higher. Reliable 3G, 4G, 5G, WiFi or mobile network access.

In addition SEMIC EyeScan® detects:


t is the most common cancer among all others, spreading in both developed and developing countries. SEMIC EyeScan® was developed to help physicians and individuals upload an image to diagnose the individual types of tumorous lesions:

  • Disorder
  • Actinic Keratoses
  • Intraepithelial Carcinoma
  • Basal Cell Carcinoma
  • Benign Keratosis
  • Dermatofibroma
  • Melanocytic Nevi
  • Melanoma
  • Vascular Skin Lesions


Other Diseases

  • Dengue Fever
  • Zika Virus
  • Bile disorders
  • Diabetes
  • Floater
  • Hepatitis
  • Influenza
  • Leaky gut syndrome
  • Liver diseases
  • Lung diseases
  • Stomach tumors                               
  • Spondylitis
  • Typhus
  • Uterine fibroids



SEMIC EyeScan® predicts Alzheimer’s up to 15 years before the onset of disease.


SEMIC EyeScan® predicts Parkinson’s up to 15 years before the onset of disease.

SEMIC EyeScan® enables the detection of:

  • Alcohol
  • Drugs
  • Nicotine